K Aksu, E Kurt. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » 2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage2-Pyridinylmethylsulfinylbenzimidazoles/adverse effectsAdultAnaphylaxis/etiologyAnaphylaxis/prevention & controlAnti-Ulcer Agents/administration & dosageAnti-Ulcer Agents/adverse effectsDrug Hypersensitivity/complicationsDrug Hypersensitivity/drug therapyFemaleHumansImmunizationLansoprazoleMiddle AgedOmeprazole/administration & dosageOmeprazole/adverse effectsPeptic Ulcer/complicationsPeptic Ulcer/drug therapy
Substances： See more » 2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer AgentsLansoprazoleOmeprazole
Year: 2011 PMID： 22115571 DOI： 10.1016/j.aller.2011.09.006
Source DB: PubMed Journal: Allergol Immunopathol (Madr) ISSN： 0301-0546 Impact factor: 1.667